WO2006136289A1 - Verfahren zur herstellung von enantiomerenreinen epoxiden durch adh-reduktion von alpha-abgangsgruppen-substituierten ketonen und cyclisierung - Google Patents
Verfahren zur herstellung von enantiomerenreinen epoxiden durch adh-reduktion von alpha-abgangsgruppen-substituierten ketonen und cyclisierung Download PDFInfo
- Publication number
- WO2006136289A1 WO2006136289A1 PCT/EP2006/005437 EP2006005437W WO2006136289A1 WO 2006136289 A1 WO2006136289 A1 WO 2006136289A1 EP 2006005437 W EP2006005437 W EP 2006005437W WO 2006136289 A1 WO2006136289 A1 WO 2006136289A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- epoxides
- reduction
- oso
- substituted
- cofactor
- Prior art date
Links
- 150000002576 ketones Chemical class 0.000 title claims abstract description 10
- 150000002118 epoxides Chemical class 0.000 title claims abstract 6
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims abstract description 17
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims abstract description 15
- 150000001298 alcohols Chemical class 0.000 claims abstract description 12
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 7
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 7
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 6
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 6
- -1 alkenyl radical Chemical class 0.000 claims abstract description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
- 239000001257 hydrogen Substances 0.000 claims abstract description 3
- 150000003254 radicals Chemical class 0.000 claims abstract description 3
- 230000001172 regenerating effect Effects 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 33
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 238000007363 ring formation reaction Methods 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 9
- 230000002255 enzymatic effect Effects 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims 2
- 125000000520 N-substituted aminocarbonyl group Chemical group [*]NC(=O)* 0.000 abstract 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract 1
- 150000002924 oxiranes Chemical class 0.000 description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- WSDDJLMGYRLUKR-WUEGHLCSSA-L disodium;[(2r,3r,4r,5r)-2-(6-aminopurin-9-yl)-5-[[[[(2r,3s,4r,5r)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] hydrogen phosphate Chemical compound [Na+].[Na+].NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP([O-])([O-])=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 WSDDJLMGYRLUKR-WUEGHLCSSA-L 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 238000005356 chiral GC Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YVMKRPGFBQGEBF-QMMMGPOBSA-N (2r)-2-(3-chlorophenyl)oxirane Chemical compound ClC1=CC=CC([C@H]2OC2)=C1 YVMKRPGFBQGEBF-QMMMGPOBSA-N 0.000 description 1
- ICVNPQMUUHPPOK-MRVPVSSYSA-N (2s)-2-(4-fluorophenyl)oxirane Chemical compound C1=CC(F)=CC=C1[C@@H]1OC1 ICVNPQMUUHPPOK-MRVPVSSYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- VQDWDBUIFQAOHE-UHFFFAOYSA-N 1,5-dichloropentane-2,3,4-trione Chemical class ClCC(=O)C(=O)C(=O)CCl VQDWDBUIFQAOHE-UHFFFAOYSA-N 0.000 description 1
- UJZWJOQRSMOFMA-UHFFFAOYSA-N 2-chloro-1-(4-fluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CCl)C=C1 UJZWJOQRSMOFMA-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000033325 Cystofilobasidium macerans Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 101100080807 Drosophila melanogaster mt:ND2 gene Proteins 0.000 description 1
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 description 1
- 101150016680 MT-ND2 gene Proteins 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- 102100028488 NADH-ubiquinone oxidoreductase chain 2 Human genes 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 101150102231 ND2 gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 244000037640 animal pathogen Species 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 description 1
- 239000004914 cyclooctane Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- BDOLXPFAFMNDOK-UHFFFAOYSA-N oxazaborolidine Chemical class B1CCON1 BDOLXPFAFMNDOK-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
- C07D301/24—Synthesis of the oxirane ring by splitting off HAL—Y from compounds containing the radical HAL—C—C—OY
- C07D301/26—Y being hydrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
Definitions
- the invention relates to a process for the preparation of enantiomerically pure epoxides by (R) - or (S) -alkanol dehydrogenase reduction of ⁇ -leaving group-substituted ketones to the corresponding enantiomerically pure alcohols and subsequent base-induced cyclization to the corresponding enantiomerically pure epoxides (EQUATION 1 ).
- Catalytic enantioselective standard chemical processes for the enantioselective reduction of ketones include asymmetric hydrogenation with homogeneous noble metal catalysts, reduction by organoboranes [H. C. Brown, G.G. Pai, J. Org. Chem. 1983, 48, 1784; ] derived from borohydrides and chiral diols or aminoalcohols [K. Soai, T. Yamanoi, H. Hikima, J. Organomet. Chem. 1985, 290; H.C. Brown, B.T. Cho, W.S. Park, J. Org. Chem. 1987, 52, 4020], the reduction by reagents prepared from borane and aminoalcohols [S.
- the catalytic enantioselective standard biochemical processes for the preparation of enantiomerically pure epoxides use fermentatively baker's yeast (Saccharomyces cerevisiae) [M. de Carvalho, MT Okamoto, PJS Moran, JAR Rodrigues, Tetrahedron 1991, 47, 2073] or other microorganisms [EP 0 198 440 B1] in the so-called "whole cell method", Cryptococcus macerans [M.Imuta, KI Kawai, H. Par., J. Org. Chem. 1980, 45, 3352], or a combination from NADH2 and horse liver ADH [DD Tanner, AR Stein, J. Org. Chem. 1988, 53, 1642.].
- the present process solves all of these problems and relates to a process for preparing enantiomerically pure epoxides by reducing ⁇ -leaving group substituted ketones with an (R) or (S) alcohol dehydrogenase (ADH) enzyme in the presence of a cofactor and optionally a suitable one
- a system for regenerating the oxidized cofactor to the corresponding enantiomerically pure alcohols and subsequent base-induced cyclization to the corresponding enantiomerically pure epoxides (EQUATION 1), wherein
- Suitable ADH enzymes are (R) - or (S) -alcohol dehydrogenases.
- isolated (cell-free) ADH enzymes are used with an enzyme activity of
- Enzyme activity per mole of substrate most preferably 1 to 50 kU of enzyme activity per mole of substrate.
- the enzyme is preferably used catalytically to superstoichiometrically with respect to the starting compound.
- Suitable cofactors are NADPH 2 , NADH 2 , NAD or NADP, more preferably NAD or NADP are used. Preference is given to loading with 0.1 to 10 g of cofactor per 10 mol of substrate, more preferably 0.5 to 1.5 g of cofactor per 10 mol of substrate.
- the inventive method is carried out so that in the presence of a suitable system for Regeneration of the oxidizing cofactor worked and this is continuously recycled during the process.
- a suitable system for Regeneration of the oxidizing cofactor typically enzymatic or other methods known to those skilled in the art are used.
- the cofactor is recycled continuously and can thus be used in several oxidation / reduction cycles.
- Another common method is the use of a second enzyme system in the reactor.
- Two methods described in detail include the use of formate dehydrogenase for the oxidation of formic acid to carbon dioxide, or the use of glucose dehydrogenase for the oxidation of glucose, to name only a few.
- the reaction is carried out in a solvent.
- suitable solvents for the ADH reduction are those which do not give rise to side reactions, these are organic solvents such as e.g. Methanol, ethanol, isopropanol, linear and branched alcohols, ligroin, butane, pentane, hexane, heptane, octane, cyclopentane, cyclohexane, cycloheptane,
- Cyclooctane dichloromethane, chloroform, carbon tetrachloride, 1, 2-dichloroethane, 1, 1, 2,2-tetrachloroethane, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, dimethylformamide, diethylformamide, dimethylacetamide, diethylacetamide, diethyl ether, diisopropyl ether, tert-butyl methyl ether, THF, dioxane, acetonitrile or mixtures of these.
- Methanol, ethanol, isopropanol, diisopropyl ether, tert-butyl methyl ether, tetrahydrofuran (THF), dioxane, or mixtures thereof very particularly preferred are ethanol, isopropanol, linear and branched alcohols, diethyl ether, diisopropyl ether, tert-butyl methyl ether, THF , Dioxane, or mixtures of these.
- the process can also be carried out without addition of solvent.
- a buffer to the reaction solution in order to stabilize the pH and to ensure that the enzyme can react in the optimum pH range for it.
- the optimum pH range differs from enzyme to enzyme and is usually in the range of pH 3 to 11. Suitable buffer systems are known to the person skilled in the art, so that it is not necessary to discuss this further here.
- the reduction to the alcohols (IIa) or (IIb) can be carried out generally at temperatures ranging from -100 to +120 C c, are preferred temperatures in the range of -30 to +50 0 C, more preferably temperatures in the range from 0 to +40 0 C, with lower temperatures generally correlated with higher selectivities.
- the reaction time depends on the temperature used and is generally 1 to 72 hours, especially 4 to 45 hours.
- the ee values of the intermediately produced alcohols are significantly> 95% ee, in most cases> 99% with simultaneously very high tolerance to functional groups in the substrate.
- the cyclization of the alcohols (IIa) or (IIb) to the epoxides can be carried out generally at temperatures in the range of -100 to +120 0 C, preferred are temperatures in the range of -30 to +50 0 C, more preferably temperatures in the range of 0 to + 4O 0 C.
- the reaction time depends on the temperature used, and is generally 1 to 72 hours, especially 24 to 60 hours. Sufficient conversion can be ensured here, for example, by GC or HPLC reaction control.
- the reaction solution is heated to the reaction temperature before addition of the ADH enzyme.
- Amine bases carbonates, bicarbonates, hydroxides, hydrides, alcoholates, phosphates, hydrogen phosphates, more preferably tertiary amines, most preferably sodium hydroxide, potassium hydroxide, triethylamine or pyridine.
- the base is preferably used stoichiometrically or superstoichiometrically with respect to the compound (Ia) or (IIb).
- the isolation of the products is preferably carried out either by distillation or by crystallization.
- the ee values are significantly greater than 99%, which means that no further purification is necessary.
- the substrate breadth of this new technology is very high. It is possible to use ⁇ -leaving group-substituted ketones with aryl radicals of different substitution pattern as well as aliphatic halomethyl ketones. Chloroacetyl ketones react in particularly good yields and high ee values.
- the new process provides a very wide range of enantiomerically pure epoxides in very high yields of> 85%, usually> 90%, and very high ee values, whereby both enantiomers can be obtained depending on the enzyme used.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Epoxy Compounds (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002612407A CA2612407A1 (en) | 2005-06-18 | 2006-06-07 | Method for producing single enantiomer epoxides by the adh reduction of alpha-leaving group-substituted ketones and cyclisation |
EP06754193A EP1899313A1 (de) | 2005-06-18 | 2006-06-07 | Verfahren zur herstellung von enantiomerenreinen epoxiden durch adh-reduktion von alpha-abgangsgruppen-substituierten ketonen und cyclisierung |
US11/917,777 US20080206826A1 (en) | 2005-06-18 | 2006-06-07 | Method for Producing Single Enantiomer Epoxides by the Adh Reduction of a-Leaving Group-Substituted Ketones and Cyclization |
JP2008516180A JP2008543293A (ja) | 2005-06-18 | 2006-06-07 | α−脱離基で置換されたケトンのADH還元および環化による単一の鏡像異性体エポキシドの製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005028312.8 | 2005-06-18 | ||
DE102005028312A DE102005028312B4 (de) | 2005-06-18 | 2005-06-18 | Verfahren zur Herstellung von enantiomerenreinen Epoxiden durch ADH-Reduktion von α-Abgangsgruppen-substituierten Ketonen und Cyclisierung |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006136289A1 true WO2006136289A1 (de) | 2006-12-28 |
Family
ID=36997479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/005437 WO2006136289A1 (de) | 2005-06-18 | 2006-06-07 | Verfahren zur herstellung von enantiomerenreinen epoxiden durch adh-reduktion von alpha-abgangsgruppen-substituierten ketonen und cyclisierung |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080206826A1 (de) |
EP (1) | EP1899313A1 (de) |
JP (1) | JP2008543293A (de) |
CN (1) | CN101184742A (de) |
CA (1) | CA2612407A1 (de) |
DE (1) | DE102005028312B4 (de) |
WO (1) | WO2006136289A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008064817A2 (de) * | 2006-11-30 | 2008-06-05 | Archimica Gmbh | Verfahren zur stereoselektiven synthese von chiralen epoxiden durch adh-reduktion von alpha-abgangsgruppen-substituierten ketonen und cyclisierung |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011005527A2 (en) | 2009-06-22 | 2011-01-13 | Codexis, Inc. | Ketoreductase-mediated stereoselective route to alpha chloroalcohols |
WO2011100265A2 (en) | 2010-02-10 | 2011-08-18 | Codexis, Inc. | Processes using amino acid dehydrogenases and ketoreductase-based cofactor regenerating system |
DE102012017026A1 (de) | 2012-08-28 | 2014-03-06 | Forschungszentrum Jülich GmbH | Sensor für NADP(H) und Entwicklung von Alkoholdehydrogenasen |
CN113831218B (zh) * | 2020-06-23 | 2023-11-28 | 利尔化学股份有限公司 | 一种制备4-氟苯基环氧乙烷的方法 |
CN114317620B (zh) * | 2020-09-29 | 2024-02-02 | 上海医药工业研究院 | 一种(r)-2-(2-氯苯基)环氧乙烷的生物制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002064579A1 (de) * | 2001-02-09 | 2002-08-22 | Forschungszentrum Jülich GmbH | Verfahren zur herstellung von optisch aktiven, propargylischen, terminalen epoxiden |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USH1893H (en) * | 1996-07-23 | 2000-10-03 | Bristol-Myers Squibb Company | Enzymatic reduction method for the preparation of halohydrins |
US20060177913A1 (en) * | 2005-02-08 | 2006-08-10 | Consortium Fur Elektrochemische Industrie Gmbh | Process for enantioselective enzymatic reduction of keto compounds |
-
2005
- 2005-06-18 DE DE102005028312A patent/DE102005028312B4/de not_active Expired - Fee Related
-
2006
- 2006-06-07 US US11/917,777 patent/US20080206826A1/en not_active Abandoned
- 2006-06-07 CN CNA2006800183415A patent/CN101184742A/zh active Pending
- 2006-06-07 CA CA002612407A patent/CA2612407A1/en not_active Abandoned
- 2006-06-07 WO PCT/EP2006/005437 patent/WO2006136289A1/de active Application Filing
- 2006-06-07 EP EP06754193A patent/EP1899313A1/de not_active Withdrawn
- 2006-06-07 JP JP2008516180A patent/JP2008543293A/ja not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002064579A1 (de) * | 2001-02-09 | 2002-08-22 | Forschungszentrum Jülich GmbH | Verfahren zur herstellung von optisch aktiven, propargylischen, terminalen epoxiden |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008064817A2 (de) * | 2006-11-30 | 2008-06-05 | Archimica Gmbh | Verfahren zur stereoselektiven synthese von chiralen epoxiden durch adh-reduktion von alpha-abgangsgruppen-substituierten ketonen und cyclisierung |
WO2008064817A3 (de) * | 2006-11-30 | 2008-07-17 | Archimica Gmbh | Verfahren zur stereoselektiven synthese von chiralen epoxiden durch adh-reduktion von alpha-abgangsgruppen-substituierten ketonen und cyclisierung |
Also Published As
Publication number | Publication date |
---|---|
EP1899313A1 (de) | 2008-03-19 |
DE102005028312B4 (de) | 2008-05-08 |
CA2612407A1 (en) | 2006-12-28 |
JP2008543293A (ja) | 2008-12-04 |
US20080206826A1 (en) | 2008-08-28 |
DE102005028312A1 (de) | 2006-12-28 |
CN101184742A (zh) | 2008-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2086952A2 (de) | Verfahren zur stereoselektiven synthese von chiralen epoxiden durch adh-reduktion von alpha-abgangsgruppen-substituierten ketonen und cyclisierung | |
DE102005028312B4 (de) | Verfahren zur Herstellung von enantiomerenreinen Epoxiden durch ADH-Reduktion von α-Abgangsgruppen-substituierten Ketonen und Cyclisierung | |
WO2009077550A1 (de) | Verfahren zur herstellung von cis-rosenoxid | |
EP1797191B1 (de) | Verfahren zur herstellung von optisch aktiven 2-methylalkan-1-olen aus den entsprechenden 2-methylalk-2-en-1-alen, umfassend einen schritt der enantioselektiven acylierung zwecks anreicherung eines enatiomers | |
AT501928B1 (de) | Verfahren zur herstellung von chiralen alkoholen | |
EP1175382B1 (de) | Verfahren zur dihydroxylierung von olefinen mittels übergangsmetall-katalysatoren | |
WO2008055988A2 (de) | Verfahren zur herstellung von (4s)-3, 4-dihydroxy-2,6, 6-trimethyl-cyclohex-2-enon und derivaten davon unter verwendung der azoarcus phenylethanol dehydrogenase | |
EP1969133B1 (de) | Verfahren zur herstellung von optisch aktivem (1s)-3-chlor-1-(2-thienyl)-propan-1-ol | |
US7294492B2 (en) | Process for the manufacture of spiroketals | |
DE102006055047A1 (de) | Verfahren zur Herstellung von Dihydroxy-Verbindungen aus Diketo-Verbindungen durch enzymkatalysierte enantioselektive Reduktion | |
EP1163206B1 (de) | Verfahren zur hydrolyse von optisch aktiven amiden | |
DE3878264T2 (de) | Monoacetylierung von diolen mit einem biokatalysator aus corynebakteriumoxidans. | |
EP1786913A2 (de) | Verfahren zur herstellung von diarylcycloalkylderivaten | |
DE10152113C1 (de) | Verfahren zur Herstellung von (R)- und (S)-8-Chlor-6-hydroxy-octansäurealkylestern durch enzymatische Reduktion | |
DE102013211075B9 (de) | Biotechnologisches Verfahren zur Herstellung von substituierten oder unsubstituierten Phenylessigsäuren und Ketonen mit Enzymen des mikrobiellen Styrolabbaus | |
Motallebi et al. | Saccharomyces cerevisiae as a biocatalyst for different carbonyl group under green condition | |
Francis | The Synthesis and Biocatalytic Reduction of Beta-keto Alkynes | |
EP1175379B1 (de) | Verfahren zur asymmetrischen dihydroxylierung von olefinen mittels osmium-katalysatoren | |
EP1358173A1 (de) | Verfahren zur herstellung von optisch aktiven, propargylischen, terminalen epoxiden | |
CN104263776A (zh) | 一种生物催化生产手性吡啶乙醇的方法 | |
Karabacak | Aspergillus niger mediated a-hydroxylation of cyclic ketones | |
DE102005038606A1 (de) | Verfahren zur enzymatischen Herstellung von chiralen 1-acylierten 1,2-Diolen | |
CN104313075A (zh) | 一种光活性溴吡啶乙醇的细胞生产方法 | |
CN104313062A (zh) | 一种细胞催化生产光活性苯乙醇的方法 | |
CN104263773A (zh) | 一种生物法生产二氧基庚烯醇的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 200680018341.5 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008516180 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006754193 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4829/KOLNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11917777 Country of ref document: US Ref document number: 2612407 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2006754193 Country of ref document: EP |